Dorsey Wright & Associates’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.9M Sell
43,676
-23,663
-35% -$4.17M 1% 36
2026
Q1
$12.1M Buy
+67,339
New +$11.5M 1.5% 21
2022
Q2
Sell
-16,071
Closed -$3.55M 269
2022
Q1
$3.55M Sell
16,071
-8,969
-36% -$1.89M 0.83% 52
2021
Q4
$5.85M Buy
25,040
+444
+2% +$110K 1.21% 22
2021
Q3
$5.39M Buy
24,596
+8,633
+54% +$1.84M 1.18% 18
2021
Q2
$2.69M Sell
15,963
-23,866
-60% -$3.85M 0.57% 86
2021
Q1
$5.82K Buy
39,829
+24,618
+162% +$3.95M 0.07% 168
2020
Q4
$2.24M Buy
+15,211
New +$1.81M 0.33% 92
2018
Q1
Sell
-67,854
Closed -$8.68M 116
2017
Q4
$8.68M Buy
67,854
+5,938
+10% +$805K 1.57% 10
2017
Q3
$8.44M Buy
61,916
+3,492
+6% +$415K 1.95% 8
2017
Q2
$6.17M Sell
58,424
-684
-1% -$74.4K 1.9% 4
2017
Q1
$6.24M Buy
59,108
+34,160
+137% +$3.32M 2.14% 3
2016
Q4
$2.15M Buy
24,948
+6,789
+37% +$575K 0.91% 35
2016
Q3
$1.55M Buy
+18,159
New +$1.5M 0.74% 44

Other funds holding ALB

Dorsey Wright & Associates's ALB Position: Q2 2026 in Review

Dorsey Wright & Associates reduced its Albemarle (ALB) stake by 35% in Q2 2026, selling an estimated $4.17M and leaving 43,676 shares worth $5.9M. The position accounts for 1% of the portfolio, ranked #36.

Dorsey Wright & Associates first reported a position in ALB in Q3 2016 and has held it in 14 quarters since. The position peaked at $12.1M in Q1 2026. 739 funds tracked by Wall St. Rank hold ALB as of Q2 2026.

  • Dorsey Wright & Associates held 43,676 shares of Albemarle worth $5.9M as of Q2 2026.
  • Dorsey Wright & Associates sold 23,663 Albemarle shares in Q2 2026, an estimated $4.17M.
  • Albemarle made up 1% of Dorsey Wright & Associates's portfolio in Q2 2026, its #36 holding.
  • Dorsey Wright & Associates first reported a position in Albemarle in Q3 2016 and has held it in 14 quarters since.
  • Dorsey Wright & Associates's Albemarle position peaked at $12.1M in Q1 2026.
  • 739 funds tracked by Wall St. Rank held Albemarle as of Q2 2026.

Based on Dorsey Wright & Associates's 13F filing for Q2 2026, filed 6 Aug 2026.